Resultado de búsqueda
ARMAND de GRAMONT. Chief Scientific Officer. Armand is one of the three founders and CSO of Onward Therapeutics SA since its inception in November 2019. From 2016 to 2019, he was Vice President Translational Sciences at PharmaEngine. From 2014 to 2016, he was Head of a research laboratory in the Oncology Department of the Lausanne University ...
Guy-Armand de Gramont, mostly just called by his second name Armand, was born on November 25 in 1637. He achieved fame due to his bravery on the battlefield, his libertine lifestyle and his scandalous affair with Philippe de France, brother to the great Sun King. Armand was the first-born child of Antoine III de Gramont,…
Armand de Gramont Galunisertib (LY2157299) is a selective ATP-mimetic inhibitor of TGF-β receptor (TβR)-I activation currently under clinical investigation in hepatocellular carcinoma (HCC ...
Armand de Gramont, comte de Guiche, né en 1637 et mort le 29 novembre 1673, est un militaire et homme de cour français. Biographie [ modifier | modifier le code ] Fils du maréchal Antoine de Gramont et de Françoise-Marguerite de Chivré, dame du Plessis et parente du cardinal de Richelieu , il est l'un des favoris et mignons du duc d'Orléans , Monsieur, frère de Louis XIV .
19 de may. de 2024 · Guy Armand de Gramont, Count of Guiche (25 November 1637 – 29 November 1673), was a French nobleman, adventurer and one of the greatest playboys of the 17th century. He was the son of Marshal Duke Antoine III de Gramont and Françoise-Marguerite du Plessis de Chivré, Richelieu 's niece. His sister was Catherine Charlotte, (1639–1678 ...
Armand de Gramont is the Co-founder and Chief Scientific Officer of Onward Therapeutics. He previously worked at PharmaEngine as a Vice-President Translational Science. Armand de Gramont attended Pierre and Marie Curie University.
Berufserfahrung: Onward Therapeutics · Ort: Metropolregion Lausanne · 337 Kontakte auf LinkedIn. Sehen Sie sich das Profil von Armand de Gramont Armand de Gramont auf LinkedIn, einer professionellen Community mit mehr als 1 Milliarde Mitgliedern, an.
- Onward Therapeutics
